Search - tctmd.com

Displaying 401 - 420 of 465

Sort: Relevancy | Date

News Daily News

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

July 30, 2012

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

May 22, 2012

News Conference News EuroPCR 2012

No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES

May 18, 2012

News Conference News EuroPCR 2012

Strong Showing for Bioabsorbable-Scaffold DES

May 16, 2012

News Conference News EuroPCR 2012

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

May 15, 2012

News Daily News

Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting

April 25, 2012

News Daily News

NY Registry Shows Improved Outcomes with PCI vs. Medical Therapy in Stable Patients

April 03, 2012

News Conference News ACC 2012

Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES

March 26, 2012

News Conference News ACC 2012

RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years

March 26, 2012

News Daily News

It’s DESTINY: DES Superior to BMS for Below-the-Knee Lesions

March 06, 2012

News Daily News

Statins Reduce Late Restenosis After SES Implantation

March 05, 2012

News Daily News

Las Estatinas Reducen la Re-estenosis Tardía tras el Implante de un SLS

March 05, 2012

News Daily News

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

February 21, 2012

News Daily News

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

February 20, 2012

News Daily News

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

January 24, 2012

News Daily News

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

January 08, 2012

News Conference News

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

November 28, 2011

News Conference News

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

November 27, 2011

News Conference News

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

November 20, 2011

News Conference News

‘Judicious Use’ of DES in Low-Risk Patients Could Save Over $200 Million per Year

November 16, 2011

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.